BIBF1120, an investigational triple angiokinase inhibitor, in combination with inhibitors of mTOR signaling shows potent antitumor activity in preclinical models of sarcoma Meeting Abstract

  

Authors:	Patwardhan, P. P.; Musi, E.; Ivy, K. S.; Giovino, N.; Schwartz, G. K.
Abstract Title:	BIBF1120, an investigational triple angiokinase inhibitor, in combination with inhibitors of mTOR signaling shows potent antitumor activity in preclinical models of sarcoma
Meeting Title:	105th Annual Meeting of the American Association for Cancer Research (AACR)
Journal Title:	Cancer Research
Volume:	74
Issue:	19 Suppl.
Meeting Dates:	2014 Apr 5-9
Meeting Location:	San Diego, CA
ISSN:	0008-5472
Publisher:	American Association for Cancer Research
Date Published:	2014-10-01
Language:	English
ACCESSION:	WOS:000349910202499
DOI:	10.1158/1538-7445.am2014-4526
PROVIDER:	wos
Notes:	Meeting Abstract: 4526 -- 105th Annual Meeting of the American-Association-for-Cancer-Research (AACR) -- APR 05-09, 2014 -- San Diego, CA -- S -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/74722